Stockscreener 앱 받기
5.74
5.13%
0.28
시간 외 거래:
5.72
-0.02
-0.35%
전일 마감가:
$5.46
열려 있는:
$5.54
하루 거래량:
134.72K
Relative Volume:
0.14
시가총액:
$140.89M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.32%
1개월 성능:
+48.32%
6개월 성능:
+59.00%
1년 성능:
+27.84%
1일 변동 폭
$5.21
$5.75
1주일 범위
$5.1921
$6.0699
52주 변동 폭
$1.47
$7.36
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
명칭
Artiva Biotherapeutics Inc
전화
(858) 267-4467
주소
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
5.74 | 134.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-11 | 재개 | H.C. Wainwright | Buy |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 개시 | Jefferies | Buy |
| 2024-08-13 | 개시 | Needham | Buy |
| 2024-08-13 | 개시 | TD Cowen | Buy |
| 2024-08-13 | 개시 | Wedbush | Outperform |
모두보기
Artiva Biotherapeutics Inc 주식(ARTV)의 최신 뉴스
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update - Yahoo Finance
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewswire
Artiva Biotherapeutics appoints Thad Huston as chief financial officer - Investing.com Australia
Artiva Biotherapeutics appoints Thad Huston as chief financial officer By Investing.com - Investing.com South Africa
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer - TipRanks
Artiva Biotherapeutics, Inc. Appoints Thad Huston as Principal Financial Officer and Principal Accounting Officer, Effective from February 18, 2026 - marketscreener.com
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant - The Globe and Mail
Artiva Biotherapeutics Announces Appointment Of Thad Huston As CFO - TradingView
Artiva Biotherapeutics Announces Appointment of Thad Huston as Chief Financial Officer and Award of Inducement Grant - GlobeNewswire Inc.
Is Artiva Biotherapeutics Inc. on track to beat earningsJuly 2025 Retail & Daily Profit Maximizing Tips - mfd.ru
Artiva Biotherapeutics Inc. (ARTV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Artiva Biotherapeutics Inc. keep up with sector leaders2025 Institutional Moves & AI Driven Stock Movement Reports - mfd.ru
Will Artiva Biotherapeutics Inc. benefit from rate cutsJuly 2025 Weekly Recap & Consistent Profit Alerts - mfd.ru
Artiva Biotherapeutics appoints pharma veteran Elaine Sorg to board By Investing.com - Investing.com India
Earnings Miss: Does Artiva Biotherapeutics Inc. have consistent dividend growthWeekly Stock Report & Precise Trade Entry Recommendations - mfd.ru
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board - The Globe and Mail
Artiva Biotherapeutics appoints pharma veteran Elaine Sorg to board - Investing.com Australia
Artiva Biotherapeutics Announces Appointment of Elaine Sorg to Board of Directors - Bitget
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer - The Manila Times
Sell Signal: Is LINKBANCORP Inc a defensive stockJuly 2025 PreEarnings & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Momentum: Does Artiva Biotherapeutics Inc have consistent dividend growth2025 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
Will Artiva Biotherapeutics Inc. stock benefit from sector rotation2025 Dividend Review & Real-Time Buy Signal Notifications - mfd.ru
Can Artiva Biotherapeutics Inc. stock continue upward trendWeekly Loss Report & Free High Accuracy Swing Entry Alerts - mfd.ru
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Short Interest Down 28.5% in January - MarketBeat
Artiva Biotherapeutics, Inc. (RTVA.US) Latest News & Headlines - Longbridge
Is Artiva Biotherapeutics Inc. stock risky to hold nowJuly 2025 Momentum & Long-Term Growth Portfolio Plans - mfd.ru
Published on: 2026-02-12 04:11:50 - mfd.ru
Will Artiva Biotherapeutics Inc. outperform its industry peersPortfolio Update Report & Community Driven Trade Alerts - mfd.ru
Is Artiva Biotherapeutics Inc. stock a good pick for beginnersQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - mfd.ru
Can Artiva Biotherapeutics Inc. stock outperform in a bear marketForecast Cut & Low Risk Investment Opportunities - mfd.ru
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives $19.00 Average PT from Brokerages - Defense World
ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Artiva Biotherapeutics executes RSU exchange for employees - MSN
Trading Action: Is Artiva Biotherapeutics Inc stock a good pick for beginnersJuly 2025 Momentum & Community Consensus Trade Signals - baoquankhu1.vn
Hedge Fund Bets: Is CFRPRB stock heavily shortedTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest - MarketBeat
Pharma News: Can AGMH outperform under higher oil pricesTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn
Brokers Set Expectations for ARTV FY2030 Earnings - Defense World
Income Plays: Is Artiva Biotherapeutics Inc.’s ROE strong enoughJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - mfd.ru
Update Report: Can Artiva Biotherapeutics Inc. outperform in the next rallyJuly 2025 Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn
Undervalued Penny Stocks To Consider In January 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at the 2026 Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR® (Tandem Meetings) Highlighting Cost-Effectiveness of AlloNK in a Community Rheumatology Practice and Contin - The Globe and Mail
Artiva Biotherapeutics Announces Upcoming Presentations at - GlobeNewswire
Take Profit: Is Artiva Biotherapeutics Inc part of any ETF2025 Price Targets & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Aug Catalysts: How do insiders feel about Artiva Biotherapeutics IncJuly 2025 Reactions & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Take Profit: Can Artiva Biotherapeutics Inc outperform in the next rallyWeekly Market Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Wall Street Recap: Is AppTech Payments Corp Equity Warrant attractive for institutional investorsJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn
Trend Recap: Will Artiva Biotherapeutics Inc outperform its industry peers2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Artiva Biotherapeutics Inc (ARTV) 재무 분석
Artiva Biotherapeutics Inc (ARTV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.69%
0.71%
자본화:
|
볼륨(24시간):